Señales en vivo de MURA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 136847 min ago

@ $4.55

Emitido: 14 feb 2024 @ 12:08

Retorno: -17.36%

Señal anterior: feb 14 - 09:34

Señal anterior: Vender

Retorno: -0.44 %

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer...

Stats
Volumen de hoy	102 504
Volumen promedio	211 817
Capitalización de mercado	63.63M
EPS	$0 ( 2024-03-14 )
Próxima fecha de ganancias	( $-2.66 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0100 (0.27%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-14	Cuss Francis M	Buy	15 021	Stock Option (right to buy)
2023-12-14	Jackson Scott Thomas	Buy	15 021	Stock Option (right to buy)
2023-12-14	Hickey Benjamin	Buy	15 021	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	146 452	Stock Option (right to buy)
2023-12-14	Cutler Adam D.	Buy	78 859	Ordinary Shares

INSIDER POWER
100.00
Last 10 transactions
Buy: 353 823 \| Sell: 0

Volumen Correlación

Largo: -0.09 (neutral)

Corto: -0.61 (weak negative)

Signal:(44.362) Neutral

Mural Oncology plc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mural Oncology plc Correlación - Moneda/Commodity

-0.36
( neutral )

0.00
( neutral )

-0.66
( moderate negative )

0.60
( weak )

Mural Oncology plc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-2.57M (0.00 %)
EPS:	$-12.43

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-11.99

Financial Reports:

No articles found.

Mural Oncology plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Mural Oncology plc

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.